WW International, has formerly known as WeightWatchers, has filed for Chapter 11 bankruptcy protection in a bid to cut its debt after hugely popular obesity drugs upended its business model.

This is a mistake. GLP-1s appear to modify addictive brain pathways that are activated by ultraformulated foods, helping ...

Following on from a remarkable study in mice, scientists have now confirmed that silencing a certain protein in muscle tissue ...

People with type 2 diabetes using GLP-1s had a lower risk for colorectal cancer than those undergoing bariatric surgery, as well as the general population.

Novo Nordisk slashed its 2025 sales forecast citing lower-than-expected penetration of its branded GLP-1 weight loss and ...

Obesity drugmaker Novo Nordisk has today downgraded its 2025 sales forecast, ending a four-year stretch of steady guidance ...

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Shares of the company, which once boasted of media mogul Oprah Winfrey as one of its top shareholders, slumped 40% in ...

Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a pill.

WW International , formerly known as WeightWatchers, has filed for Chapter 11 bankruptcy protection on Tuesday in a bid to ...

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...